A detailed history of Dakota Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dakota Wealth Management holds 34,393 shares of VRTX stock, worth $15.5 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
34,393
Previous 30,351 13.32%
Holding current value
$15.5 Million
Previous $14.2 Million 12.43%
% of portfolio
0.37%
Previous 0.34%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$460.0 - $505.78 $1.86 Million - $2.04 Million
4,042 Added 13.32%
34,393 $16 Million
Q2 2024

Jul 19, 2024

SELL
$392.81 - $485.53 $797,797 - $986,111
-2,031 Reduced 6.27%
30,351 $14.2 Million
Q1 2024

Apr 24, 2024

BUY
$407.69 - $446.08 $3.77 Million - $4.12 Million
9,240 Added 39.93%
32,382 $13.5 Million
Q4 2023

Jan 30, 2024

BUY
$343.0 - $410.68 $7.01 Million - $8.39 Million
20,427 Added 752.38%
23,142 $9.42 Million
Q3 2023

Oct 23, 2023

BUY
$338.18 - $362.46 $271,220 - $290,692
802 Added 41.92%
2,715 $944,000
Q2 2023

Jul 31, 2023

BUY
$314.42 - $351.91 $100,299 - $112,259
319 Added 20.01%
1,913 $673,000
Q1 2023

Apr 14, 2023

SELL
$283.23 - $323.1 $69,957 - $79,805
-247 Reduced 13.42%
1,594 $502,000
Q4 2022

Feb 07, 2023

SELL
$285.76 - $321.48 $135,736 - $152,703
-475 Reduced 20.51%
1,841 $531,000
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $47,646 - $53,162
174 Added 8.12%
2,316 $670,000
Q2 2022

Aug 05, 2022

SELL
$234.96 - $292.55 $32,659 - $40,664
-139 Reduced 6.09%
2,142 $604,000
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $62,219 - $73,332
281 Added 14.05%
2,281 $595,000
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $4,761 - $5,550
-23 Reduced 1.14%
2,000 $430,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $1,656 - $2,208
8 Added 0.4%
2,023 $478,000
Q3 2020

Nov 04, 2020

SELL
$255.65 - $303.1 $2.44 Million - $2.89 Million
-9,531 Reduced 82.55%
2,015 $548,000
Q2 2020

Aug 07, 2020

BUY
$225.48 - $295.8 $2.15 Million - $2.82 Million
9,546 Added 477.3%
11,546 $3.35 Million
Q1 2019

Apr 29, 2019

BUY
$163.73 - $194.7 $327,460 - $389,400
2,000 New
2,000 $368,000
Q1 2019

Apr 18, 2019

SELL
$163.73 - $194.7 $327,460 - $389,400
-2,000 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$148.13 - $162.24 $296,260 - $324,480
2,000
2,000 $304,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.